Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

SmithKline Beecham and Ribi announce positive HBV phase III trial data

Dec. 16, 1998

MedImmune and BioTransplant initiate two new clinical studies of MEDI-507

Dec. 16, 1998

Vanguard Medica takes on development of imiquimod analogue

Dec. 15, 1998

U.S. patent issues to Alexion, paving the way to improved xenotransplantation technology

Dec. 15, 1998

La Jolla presents promising primate data on new xenotransplantation Toleragen candidate

Dec. 14, 1998

OraVax and Pasteur Merieux Connaught codevelop dengue fever vaccine

Dec. 14, 1998

Ariad initiates phase I trial with AP-1903 for treatment of GVHD

Dec. 11, 1998

Strategic alliance formed with SB for intranasal flu vaccine in development at BioChem Pharma

Dec. 11, 1998

Status of FluMist influenza vaccine updated by Aviron

Dec. 11, 1998

Canadian approval obtained for first chickenpox vaccine

Dec. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...